Anti-PD1 antibodies and their use as therapeutics and diagnostics

• 收藏
• 分享

专利权人:

LTD.;BEIGENE

发明人:

SONG, Jing,LI, Kang,ZHANG, Tong,XU, Lanlan,LIU, Qi,PENG, Hao

申请号：

AU2020201069

公开号：

AU2020201069A1

申请日:

2020.02.14

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020201069A120200305.pdf#####Abstract Provided are antibodies that specifically bind to Programmed Death-1 (PDI, or CD279) and inhibit PDI-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PDI-mediated functions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/